KLK3 and posterior cortical atrophy: Nevertheless, even if serum PSA detection has facilitated PCa diagnosis at early disease stages, the lack of cancer-specificity of this biomarker has resulted in a high false-positive rate, overdiagnosis, and consequent overtreatment [20].